Your care team at the OHSU Knight Cancer Institute will include world leaders in treating blood disorders and blood cancers. Our CEO, Dr. Brian Druker, played a central role in developing  Gleevec, a lifesaving medication for chronic myeloid leukemia. We are also helping lead Beat AML, a national effort to find new treatments for acute myeloid leukemia.

We offer you:

• Doctors who are also part of OHSU’s Center for Hematologic Malignancies, with detailed expertise in even rare blood diseases.
• Team-based care, with specialists meeting often to discuss each patient and develop the most effective treatment options.
• Deep specialization, helping us precisely match treatments to your specific blood cancer or disorder.
• An emphasis on research that translates laboratory findings into patient care.
• Access to clinical trials, giving our patients the chance to try promising new therapies.

Bone marrow/stem cell transplants

Meet our immunotherapy and cell transplant therapy team. Our team has done more than 4,500 bone marrow/stem cell transplants in adults in children, putting us among the nation's top 20 transplant centers.